Krystal Biotech Inc KRYS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/07/21 EDT
70.78UNCH (UNCH)
Volume
2,138
Close
70.78quote price arrow up+0.37 (+0.53%)
Volume
79,227
52 week range
37.68 - 87.29

...

Loading . . .
  • Open70.91
  • Day High72.63
  • Day Low68.61
  • Prev Close70.41
  • 52 Week High87.29
  • 52 Week High Date03/01/21
  • 52 Week Low37.68
  • 52 Week Low Date07/13/20

Key Stats

  • Market Cap1.571B
  • Shares Out22.20M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change17.97

KEY STATS

  • Open70.91
  • Day High72.63
  • Day Low68.61
  • Prev Close70.41
  • 52 Week High87.29
  • 52 Week High Date03/01/21
  • 52 Week Low37.68
  • 52 Week Low Date07/13/20
  • Market Cap1.571B
  • Shares Out22.20M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change17.97

RATIOS/PROFITABILITY

  • EPS (TTM)-1.69
  • P/E (TTM)-41.77
  • Fwd P/E (NTM)-25.99
  • EBITDA (MRQ)-31.472M
  • ROE (MRQ)-13.00%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Krystal Biotech Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Krystal Biotech, Inc. is a clinical-stage gene therapy company. The Company is using its proprietary Skin TARgeted Delivery (STAR-D) platform to develop treatments for skin diseases. The Company’s products are directed to the treatment of monogenic and congenital skin diseases, including dystrophic epidermolysis bullosa (DEB) and autosomal recessive congenital ichthyosis (ARCI). DEB is an incurable, often fatal skin blistering condition caused by mutations in the gene...
Krish Krishnan
Chairman
Kathryn Romano CPA
Chief Accounting Officer
Address
2100 Wharton St Ste 701
Pittsburgh, PA
15203-1973
United States

Top Peers

SYMBOLLASTCHG%CHG
ALVR
Allovir Inc
23.85+1.47+6.57%
REPL
Replimune Group Inc
35.84+0.34+0.96%
ALEC
Alector Inc
16.35-0.62-3.65%
KROS
Keros Therapeutics Inc
53.11-1.24-2.28%
KURA
Kura Oncology Inc
26.15+1.15+4.60%